Catalog No.
Product Name
Application
Product Information
Citations
-
Drug intermediate
2-Amino-4-phenylthiazole is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a precursor for synthesizing suberoylanilide hydroxamic acid (SAHA) analogs, which exhibit inhibitory effects on cancer cell growth. Additionally, it is instrumental in the development of ketone histone deacetylase inhibitors, demonstrating antitumor activity in vivo. -
Drug Intermediate
tert-Butyl 4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazine-1-carboxylate serves as an important drug intermediate, facilitating the synthesis of various bioactive compounds. This reagent is valuable in research aimed at developing new pharmaceuticals, particularly in the fields of medicinal chemistry and drug discovery. Its structural characteristics enable the formation of complex molecules, making it a crucial component in the production of therapeutic agents. -
Drug Impurity
4-Chloro-2-methoxybenzonitrile is identified as a drug impurity primarily involved in pharmaceutical applications. Its presence may affect the safety and efficacy of drug formulations, making it a critical compound for analytical chemistry studies. Researchers utilize this reagent to investigate the impact of impurities in drug development and quality control processes. -
Drug Intermediate
4-Methylquinaldine is a quinoline derivative primarily utilized as a drug intermediate in chemical synthesis. This compound exhibits significant potential in the development of various pharmaceuticals, contributing to the creation of biologically active molecules. Its structural properties make it valuable for research applications in medicinal chemistry and drug formulation. -
Drug Intermediate
Trimethoxy(4-phenylbutyl)silane serves as a versatile drug intermediate, facilitating the synthesis of various active pharmaceutical ingredients. Its silane structure allows for effective incorporation into complex molecular frameworks, aiding in the development of therapeutically relevant compounds. This reagent is suitable for applications in medicinal chemistry and chemical biology, contributing to advancements in drug discovery and development. -
Drug Impurity
Ilurodoline impurity 10 is a synthetic impurity associated with the drug Ilurodoline. This compound serves as a valuable reference standard for analytical and quality control applications in the pharmaceutical industry. Its characterization is crucial for ensuring the purity and safety of Ilurodoline in drug formulation and development processes. -
Drug Impurity
Tadalafil impurity 16 is a known impurity of Tadalafil, primarily involved in the assessment of pharmaceutical quality and characterization of drug substances. This compound serves as a critical reference standard for the analysis of Tadalafil formulations, ensuring compliance with regulatory guidelines. Its presence can impact the efficacy and safety profiles of Tadalafil, making it essential for analytical and quality control applications in drug development and manufacturing. -
Drug Impurity
Arolol impurity 2 is a characterized drug impurity associated with Arolol. Due to its presence, it is essential for the assessment of pharmaceutical formulations and quality control processes. This compound is used in research to ensure the purity and safety of drug products, ultimately aiding in the development of therapeutically effective formulations. -
Drug Impurity
Rosuvastatin impurity 52 is a known impurity of the cholesterol-lowering agent Rosuvastatin, primarily affecting its purity profile. This compound is crucial for quality control and analytical studies, aiding in the assessment of synthetic processes and regulatory compliance. It is utilized in pharmaceutical research to ensure the integrity of drug formulations and to evaluate the safety and efficacy of Rosuvastatin. -
Drug Impurity
BOC-Ile-N(OCH3)CH3 is a chemical compound that serves as a drug impurity, specifically an N-derivative of isoleucine. This reagent is pivotal in pharmaceutical development and quality control, as it allows for the analysis of drug formulations and the understanding of synthesis pathways. Its relevance in research extends to evaluating the stability and purity of drug substances. -
Drug Impurity
Uradil Impurity 1 is identified as an impurity of Uradil, primarily serving as a reference standard in drug development and quality control. Its presence may affect the safety and efficacy profiles of pharmaceutical formulations, making it critical for analytical characterization. Research applications include stability testing and impurity profiling to ensure compliance with regulatory standards in drug formulation. -
Drug Intermediate
1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one Hydrochloride serves as a crucial intermediate in the synthesis of diverse bioactive compounds. This reagent is instrumental in the development of pharmaceutical agents, facilitating the exploration of novel therapeutic pathways. Its structure allows for further chemical modifications, expanding its utility in drug discovery and chemical biology research. -
Drug Intermediate
N,N-Dimethyl-2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]acetamide serves as a key drug intermediate in the synthesis of diverse biologically active compounds. This compound facilitates the development of novel pharmaceuticals through its role in organic synthesis reactions. Its structural properties make it suitable for various research applications in medicinal chemistry and drug discovery. -
Drug Impurity
2-Cyanoethyl acetoacetate is a chemical compound that serves as a drug impurity. It is significant in analytical chemistry for assessing the purity of pharmaceutical formulations and studying degradation pathways of drug candidates. Researchers utilize this reagent to investigate the stability and quality control of various therapeutic agents. -
Drug Intermediate
Methyl 3-methoxy-4-nitrobenzoate is a versatile drug intermediate that serves as a crucial building block in the synthesis of various biologically active compounds. Its unique structure supports the development of new pharmaceuticals by facilitating modifications that enhance efficacy and selectivity. This compound is particularly relevant in medicinal chemistry and organic synthesis applications, where it is utilized to create target molecules with specific therapeutic properties. -
Drug Impurity
Nintedanib impurity 3 is a chemical impurity related to Nintedanib, a receptor tyrosine kinase inhibitor. This compound is significant for analytical and quality control purposes in pharmaceutical research and development. Its identification and quantification are crucial for ensuring the safety and efficacy of Nintedanib formulations. -
Drug Intermediate
3-[(2,6-Dimethylphenoxy)methyl]-4-methoxybenzaldehyde is a versatile drug intermediate utilized in the synthesis of various bioactive compounds. This compound serves as a crucial building block in medicinal chemistry, facilitating the development of pharmaceuticals with targeted biological activities. Its utility in organic synthesis makes it an important reagent for researchers in the field of drug discovery and development. -
Drug Intermediate
3-Thiophenecarboxaldehyde is a thiophene derivative that serves as a substrate for biocatalytic reduction to 3-thiophenemethanol, facilitated by Pseudomonas putida S12 cells. This compound functions as an important intermediate in synthetic pathways. However, it exhibits toxicity toward Pseudomonas putida S12 at elevated concentrations, negatively impacting specific growth rates and final biomass yields. Its unique properties make it useful for research in biocatalysis and metabolic engineering. -
Drug Impurity
7-Deazapurine impurity 1 is a known impurity associated with the synthesis of purine derivatives. This compound may arise during the production of specific pharmaceuticals and is critical for assessing the purity and quality of drug formulations. Its analysis is essential in pharmaceutical research and development to ensure compliance with regulatory standards. -
Drug Impurity
Linagliptin impurity 34 is a chemical impurity associated with Linagliptin, a DPP-4 inhibitor. This substance is critical for the assessment of drug purity and quality control in pharmaceutical research. Its characterization and analytical evaluation are essential for understanding the metabolic profile and potential safety implications of Linagliptin formulations. -
Drug Impurity
Tofacitinib impurity 32 is a chemical impurity associated with the kinase inhibitor Tofacitinib. Its characterization is essential for assessing the purity and quality of pharmaceutical formulations. This reagent is utilized in research focused on the development and validation of analytical methods for drug analysis, as well as for stability studies in pharmaceutical sciences. -
Drug Intermediate
(2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural properties facilitate the formation of biologically active molecules, making it valuable in medicinal chemistry research. This reagent is particularly useful in the development of novel therapeutics targeting various diseases. -
Drug Impurity
Timolol impurity 1 is a known impurity of the beta-adrenergic antagonist Timolol. Its characterization is essential for quality control in pharmaceutical development, ensuring the purity and safety of the final drug product. This reagent is useful for analytical studies and method validation in drug formulation and stability testing. -
Drug Intermediate
3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile serves as a crucial drug intermediate in the synthesis of diverse bioactive molecules. This compound's structural features facilitate its utilization in medicinal chemistry for developing pharmaceuticals targeting various biological pathways. Its application in the research and synthesis of novel therapeutic agents underscores its significance in drug discovery efforts. -
Drug Intermediate
2'-Hydroxy-3,4-dimethoxydihydrochalcone serves as a drug intermediate in the synthesis of diverse bioactive compounds. This structural derivative of dihydrochalcone facilitates the production of various pharmaceuticals and agrochemicals by providing versatile chemical functionality. Its application in medicinal chemistry supports the development of novel therapeutic agents. -
Drug Impurity
Suvorexant impurity 1 is a by-product of Suvorexant synthesis, primarily associated with drug formulation and quality control. This impurity may be utilized in analytical studies to examine the effects of impurities on potency and efficacy in drug development. Research applications include stability testing and profiling of Suvorexant formulations, contributing to better understanding of safety and pharmacokinetics in preclinical studies. -
5-ASA Impurity
3-Aminosalicylic acid is a key impurity associated with the synthesis of 5-Aminosalicylic acid, a known agonist of PPARγ and an inhibitor of p21-activated kinase 1 (PAK1) and NF-κB. This compound is primarily used in research related to inflammatory bowel diseases such as Crohn's disease and ulcerative proctitis. Its role in modulating these pathways makes it significant for studies focused on therapeutic interventions and drug development in gastrointestinal conditions. -
Drug Impurity
Nintedanib impurity 7 is a known impurity associated with Nintedanib, targeting multiple receptor kinase pathways. It serves as a critical reference standard for assessing the purity of Nintedanib formulations in pharmacokinetic studies and quality control. This compound is valuable for researchers examining drug safety, efficacy, and metabolic pathways related to Nintedanib and its therapeutic applications. -
Drug Intermediate
2-Amino-6-fluoro-4-(2-methoxyethoxy)benzonitrile functions as a crucial intermediate in drug synthesis. Its unique structure facilitates the development of a range of biologically active compounds. This reagent is utilized in medicinal chemistry and pharmaceutical research for generating novel therapeutic agents. -
Drug Impurity
Afatinib impurity 36 is a chemical impurity associated with the drug Afatinib, an irreversible ErbB receptor tyrosine kinase inhibitor. This impurity is utilized in the analytical assessment of Afatinib’s purity and quality, aiding in the development and validation of pharmaceutical formulations. Its identification is essential for maintaining compliance with regulatory standards in drug manufacturing. -
Drug Intermediate
(1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the development of various therapeutic agents through its ability to participate in key chemical reactions. Its unique structure and functional groups make it an essential building block for researchers in pharmaceutical chemistry and drug discovery. -
Drug Impurity
Cannabidiol impurity 1 is a known impurity derived from Cannabidiol. This compound is often identified during the analysis and purification processes of Cannabidiol formulations. Its presence can impact the purity and potency of cannabinoid products, making it relevant for quality control and regulatory compliance in pharmaceutical and nutraceutical research. -
Drug Intermediate
tert-Butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate is a drug intermediate utilized in the synthesis of diverse pharmacologically active compounds. This compound serves as a key building block in medicinal chemistry, facilitating the development of novel therapeutic agents. Its structure can be leveraged in research applications focused on drug discovery and design. -
Drug Impurity
6,7-Dihydropyrazino[2,3-d]pyridazine-5,8-dione is identified as a drug impurity that may arise during the synthesis of pharmaceutical compounds. Its presence can impact the purity and safety profile of drug formulations. This compound is important for research applications that focus on the characterization and quantification of impurities in drug development and quality control processes. -
Drug Intermediate
(R)-1,4-Dibenzyl-2-(chloromethyl)piperazine serves as a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical compounds. Its structural characteristics enable chemists to leverage this reagent in various synthetic pathways. This compound is essential for producing molecules with potential therapeutic applications in medicinal chemistry research. -
Drug Intermediate
5-Methoxyquinolin-8-amine is a synthetic intermediate primarily utilized in the preparation of N-phthaloyl amino acid derivatives. This compound serves as a valuable building block in organic synthesis, facilitating the development of various bioactive molecules. Its unique structural features make it a crucial reagent in pharmaceutical research and development applications. -
Drug Intermediate
tert-Butyl (trans-3-(pyridin-4-yloxy)cyclobutyl)carbamate serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This reagent is instrumental in medicinal chemistry for the development of novel therapeutics through various synthetic pathways. Its unique structure facilitates specific interactions, making it valuable for investigations in pharmaceutical research. -
Drug Impurity
Butenafine impurity 2 is a drug impurity related to Butenafine, a compound primarily used as an antifungal agent. This impurity can be crucial for analytical studies and quality control in pharmaceutical development. Its characterization helps ensure the safety and efficacy of Butenafine formulations in research and clinical applications. -
Drug Intermediate
Thiophene-2-amidoxime is a synthetic compound that serves as a valuable intermediate in pharmaceutical synthesis. This reagent plays a critical role in the preparation of bioactive molecules, facilitating the development of novel therapeutic agents. Its unique chemical structure makes it suitable for various chemical transformations in drug discovery and development processes. -
Drug Impurity
Atenolol impurity 5 (p-Hydroxy pheny lacetamide) serves as a drug impurity of Atenolol. This compound is significant for analytical chemistry applications, particularly in the quality control and pharmacokinetic studies of Atenolol formulations. It aids in assessing the purity and safety profiles of Atenolol and can be utilized in method development for impurity identification and quantification. -
Drug Intermediate
5-Bromo-2-chloro-N-ethylpyrimidin-4-amine serves as a crucial drug intermediate in pharmaceutical synthesis. It is utilized in the preparation of various bioactive compounds, making it valuable for medicinal chemistry research and development. Its structural attributes enable modifications that can lead to the discovery of new therapeutic agents. -
Drug Intermediate
2-Acetoxyacetic acid serves as a valuable drug intermediate in the synthesis of truncated sidroxil derivatives. Its unique chemical structure facilitates various chemical reactions crucial in pharmaceutical research and development. This compound is essential for synthesizing complex molecules, aiding in the exploration of therapeutic options within medicinal chemistry. -
Drug Intermediate
8-Chloroisoquinolin-3(2H)-one serves as a critical drug intermediate in the synthesis of various bioactive compounds. This compound is instrumental for researchers focused on developing pharmaceuticals targeting a range of biological pathways. Its unique structure enables diverse applications in medicinal chemistry and drug discovery research. -
Drug Intermediate
Diphenylmethane functions as a key drug intermediate in pharmaceutical synthesis. Its aromatic structure allows for versatile applications, including use as an oxidizing agent in the fragrance industry, a synergist in pesticides, and a plasticizer in dye formulations. This compound plays an essential role in enhancing the efficacy of various chemical processes, making it valuable across multiple research applications in organic and medicinal chemistry. -
Drug Intermediate
Tert-Butyl (R)-2-(3-(3-(3,4-dimethoxyphenyl)-1-hydroxypropyl)phenoxy)acetate serves as a key drug intermediate in the synthesis of various bioactive compounds. Its structural components facilitate modifications that are crucial for developing targeted therapeutics. This reagent is essential in medicinal chemistry and structure-activity relationship studies, enabling researchers to explore novel pharmaceutical agents. -
Drug Intermediate
Pyrimidin-4-yl-methanol is a synthetic intermediate commonly utilized in pharmaceutical synthesis. It serves as a crucial building block for the construction of various biologically active compounds. This reagent is significant for drug development, particularly in the creation of therapeutic agents targeting diverse diseases. -
Drug Intermediate
tert-Butyl 1-(hydroxymethyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate hydrochloride serves as a key drug intermediate in the synthesis of various biologically active compounds. This reagent facilitates the development of pharmacologically relevant molecules, contributing to research in medicinal chemistry and drug discovery. Its unique structural features enable the exploration of diverse chemical pathways and enhance the understanding of therapeutic potentials. -
Drug Intermediate
9-Acetyl-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one serves as a valuable drug intermediate in the synthesis of diverse bioactive compounds. This compound is utilized in pharmaceutical research and development, facilitating the creation of novel therapeutics through its unique structural properties. Its role in medicinal chemistry makes it a crucial component for drug design and optimization efforts. -
Drug Intermediate
3-Bromo-4-chlorobenzoic acid is a key drug intermediate utilized in the synthesis of various active pharmaceutical compounds. Its structural attributes facilitate the development of targeted therapeutic agents, enhancing research in medicinal chemistry. This compound serves as a valuable building block for the advancement of novel pharmaceuticals. -
Drug Intermediate
5-Methylthiazol-2-amine hydrochloride serves as a crucial drug intermediate, playing a significant role in the synthesis of diverse active pharmaceutical compounds. This reagent is essential for research involving thiazole derivatives and their biological activities, promoting advancements in medicinal chemistry and drug discovery applications. Its utility in the development of novel therapeutics makes it a valuable resource for researchers focused on pharmaceutical development.
